Article
Novel chloroquine derivative suppresses melanoma cell growth by DNA damage through increasing ROS levels.
Journal of cellular and molecular medicine - 1 May 2022
Li Jiaoduan, Long Jing, Zhang Jianglin, Liu Nian, Yan Bei, Tang Ling, Chen Xiang, Peng Cong
Abstract excerpt
Melanoma is a fatal cancer with a significant feature of resistance to traditional chemotherapeutic drugs and radiotherapy. A mutation in the kinase BRAF is observed in more than 66% of metastatic melanoma cases. Therefore, there is an urgent need to develop new BRAF-mutant melanoma inhibitors. High-dose chloroquine has been reported to have antitumour effects, but it often induces dose-limiting toxicity. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
